Indication
Elevated IMR (>32)
1 clinical trial
1 product
Clinical trial
A Randomised Trial to Evaluate the Efficacy of Low-dose Intracoronary Tenecteplase in ST-Elevation Myocardial Infarction (STEMI) Patients With High Microvascular Resistance Post-percutaneous Coronary Intervention (PCI).Status: Recruiting, Estimated PCD: 2024-12-31
Product
Tenecteplase